Trial intelligence / Profile preview

Excretion, PK, and Metabolism of PCO371 in Healthy Males

NCT04649216Phase 1Completed

Sponsor
Chugai Pharmaceutical Co., Ltd.
Start
Nov 2020
Primary completion
Dec 2020
Countries
1
01

Overview

Phase 1, open-label trial of PCO-371 (2 arms), sponsored by Chugai Pharmaceutical Co., Ltd. Started Nov 2020; status: completed.

02

Drugs

PCO-371

Beyond the preview

Go deeper on NCT04649216.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04649216.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call